PAK2 and head and neck squamous cell carcinoma: Despite absence of PAK2 copy losses in HNSCC, lack of upregulated PAK2 expression may improve inhibitor responses by similar mechanism in the 30% of HNSCCs without PAK2 copy gain on 3q in TCGA.